Use of Intrauterine Devices and Risk of Human Immunodeficiency Virus Acquisition Among Insured Women in the United States
Author(s) -
Julia L. Marcus,
Jonathan M. Snowden,
Mara E. Murray Horwitz,
Sengwee Toh,
Casie Horgan,
Rong Chen Tilney,
Rajani Rajbhandari,
Soowoo Back,
Daniel Westreich
Publication year - 2019
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciz791
Subject(s) - medicine , human immunodeficiency virus (hiv) , intrauterine device , levonorgestrel , family planning , obstetrics , gynecology , population , virology , environmental health , research methodology
Concerns have been raised about progestin-containing contraceptives and the risk of human immunodeficiency virus (HIV) acquisition. Based on health insurance data from women in the United States with intrauterine device (IUD) insertions during 2011-2018, there was no increased risk of incident HIV diagnosis for levonorgestrel-releasing IUDs versus copper IUDs.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom